AltheaDx
Castle Biosciences to Acquire AltheaDx for $65M
Castle said the move furthers its mid- and long-term growth plans with a strategic advance into pharmacogenomics and mental health.
Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More
A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.
AltheaDx Closes $27M Series D Round
The financing, which comes on the heels of a $30 million Series C round, will be used for operating capital.